Abstract:Abstract Abstract 811 Erythropoiesis is the process during which multipotential hematopoietic stem cells proliferate, differentiate and generate mature erythrocytes. Eight distinct developmental stages have been identified which include two functionally defined erythroid progenitor cells, the burst-forming unit-erythroid (BFU-E) and the colony-forming unit-erythroid (CFU-E). The other six morphologically distinguishable stages consist of proerythroblast, basophilic erythroblast, polychromatic erythroblast, orthochromatic erythroblast, reticulocyte and mature erythrocyte. During this differentiation process many dramatic cellular and membrane changes occur which include decrease in cell size, enhanced chromatin condensation, progressive hemoglobinization, enucleation and assembly of a unique erythrocyte membrane. We have recently demonstrated that during murine erythropoiesis, membrane proteins undergo ordered assembly. Of particular note, surface expression of CD44 exhibited a progressive and a dramatic 30-fold decrease from proerythroblast to reticulocyte. Importantly, use of surface expression of CD44 and glycophorin A in conjunction with cell size has enabled us to devise a new strategy for distinguishing unambiguously distinct stages of erythroid cells during terminal murine erythroid differentiation (Chen, et al PNAS, 2009). In the present study, we examined the expression of membrane proteins during human erythropoiesis by studying expression of various membrane proteins during in vitro induced erythroid differentiation of CD34+ hematopoietic stem cells from cord blood in two phase culture system. We found a number of similarities and some differences in the expression pattern of various membrane proteins between human and mouse erythroblasts. While surface expression of CD44 also decreased during terminal erythroid differentiation of human cells, the extent of decrease was half that seen for mouse cells. Furthermore, while expression of LU and ICAM-4 decreased during terminal differentiation of mouse cells, the expression of these two proteins involved in adhesive interactions increased in human cells. Surface expression of the anion channel, band 3 and glucose transporter, GLUT1 increased dramatically at the late stages of erythroid differentiation. Using CD44 and band 3 (or GLUT1) as surface markers, we were able to obtain pure populations of human erythroblasts (~90%) at distinct stages of erythroblasts from proerythroblasts to orthochromatic erythroblasts. Furthermore, we also examined the expression of CD34, IL3 receptor and CD36 during early stages of differentiation of pure populations of CD34+ cells during the first phase of the two phase culture system. While expression of CD34 and IL3 receptor are decreased with time, expression of CD36 increased over time. Colony forming assay revealed that while sorted CD34+CD36−IL3R+ cells were significantly enriched for BFU-e progenitors, CD34−CD36+IL-3R− cells were predominantly CFU-e progenitors. These findings have thus enabled us to clearly distinguish erythroid progenitors and erythroblasts at successive developmental stages during human erythropoiesis and in conjunction with cell sorting obtain highly pure populations of erythroblasts at distinct stages of maturation. The experimental strategy we have developed should enable quantitative assessment of defining stage-specific defects in erythroid maturation in inherited and acquired red cell disorders and in bone marrow failure syndromes. Disclosures: No relevant conflicts of interest to declare.

Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis

Assay optimization for the objective quantification of human multilineage colony-forming units

Biological characterization of CD34+ cells mobilized into peripheral blood

Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells

Animal serum-free culture of purified human CD34+ cells: amplification of progenitors from G-CSF and GM-CSF-mobilized peripheral blood.

[Influence of Cytokine Combinations on Proliferation and Differentiation of Umbilical Cord Blood CD34(+) Cells into Megakaryocytes/platelets in Vitro].

Effects of Recombinant Human Macrophage Colony Stimulating Factor (Rhm-Csf)on Stromal Cell Derived During the Time of Mice Colony Formation Unit-spleen (CFU-S) and Its Role on CD34+ Cells Expansion in Vitro

Large-scale hematopoietic differentiation of human induced pluripotent stem cells provides granulocytes or macrophages for cell replacement therapies

Dynamics Of Membrane Protein Expression During Human Erythropoiesis: Resolving Distinct Maturational Stages Of Erythroid Cells

Generation of Large Numbers of Myeloid Progenitors and Dendritic Cell Precursors from Murine Bone Marrow Using a Novel Cell Sorting Strategy

Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells]

Mpl Ligand (MGDF) Alone and in Combination with Stem Cell Factor (SCF) Promotes Proliferation and Survival of Human Megakaryocyte, Erythroid and Granulocyte/Macrophage Progenitors

Experimental Study on the Effects of Granulocyte Colony-stimulating Factor and Stem Cell Factor on Proliferation and Mobilization of Bone Marrow Mononuclear Cells

The Effects of Transforming Growth Factor β3 on the Growth of Highly Enriched Hematopoietic Progenitor Cells Derived from Normal Human Bone Marrow and Peripheral Blood

[CD34 Cells and T Cell Subsets in Recombinant Human Granulocyte Colony-Stimulating Factor Primed Bone Marrow Grafts from Donors with Different Characteristics].

3045 – MAPPING MYELOID DIFFERENTIATION IDENTIFIES A CSF1+ VASCULAR NICHE FOR MYELOPOIESIS

The Effects of Several Cytokines on the Growth of Human Bone Marrow Stromal Cells

GM-CSF Stimulates Blast Cell Proliferation in Long-Term Culture of Bone Marrow from Patients with Myelodysplasia.

Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.

Low Doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after Cyclophosphamide (4 G/m2) Enhance the Peripheral Blood Progenitor Cell Harvest: Results of Two Randomized Studies Including 120 Patients

Granulocyte colony-stimulating factor directly acts on mouse lymphoid-biased but not myeloid-biased hematopoietic stem cells